RAINBOW PHARMACY
LIVE

Serial Number

98456271

Owner

RAINBOW INTERNATIONAL HOLDINGS, LLC

Attorney

SARA M. DORCHAK

First Use Date

Apr 25, 2024

Filing Date

Mar 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RAINBOW PHARMACY Trademark

Serial Number: 98456271

RAINBOW PHARMACY is a trademark filed by RAINBOW INTERNATIONAL HOLDINGS, LLC on March 19, 2024. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

RAINBOW INTERNATIONAL HOLDINGS, LLC (2 trademarks)

3901 ISLAND ESTATES DRIVE
MIAMI, FL 33160

Entity Type: 16

Trademark Details

Filing Date

March 19, 2024

Registration Date

Not Registered

First Use Anywhere

April 25, 2024

First Use in Commerce

April 25, 2024

Published for Opposition

December 31, 2024

Goods & Services

Mail order pharmacy services; Management services provided to pharmacies for controlling drug inventories; Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Retail and on-line retail store services namely, retail drug store and general consumer merchandise store services featuring home delivery service; Retail drug store services and online retail drug store services; Retail store and online retail pharmacy services; Retail store and online retail store services featuring a wide variety of consumer goods of others; Retail store services in the fields of general consumer merchandise, clothing, food, home, grocery, health, wellness, home cleaning, stationery, gardening, auto care, home office, pet care, beauty and personal care products;

Preparation of prescriptions in pharmacies; Medical clinics featuring non-emergency diagnostic and medical services in convenient locations; Developing and managing programs in the field of drug therapy and physician support services, namely, providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; Dispensing of pharmaceuticals; Health care services, namely, treatment of patients with acute and chronic conditions in the field of pain management, sleep apnea disorders, autoimmune diseases; Providing consultation in the dispensing of pharmaceuticals and pharmaceutical advice; Providing medical information regarding patients' prescription drugs and drug therapy; Providing medical information regarding prescription drugs and drug therapy;

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jun 9, 2026 SUPC
STATEMENT OF USE PROCESSING COMPLETE
Jun 9, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 9, 2026 AITU
USE AMENDMENT FILED
Feb 20, 2026 IUAF
USE AMENDMENT FILED
Feb 20, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 20, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 25, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 25, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 25, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 25, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 6, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 6, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 6, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 6, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 2, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 2, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 20, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 20, 2024 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2024 NWOS
NEW APPLICATION ENTERED
Mar 19, 2024 NWAP